<!DOCTYPE html>
<html>
  <head>
    <style>
      /*! ADAPTED
    Typeplate : Starter Kit
    URL ........... http://typeplate.com
    Version ....... 3.0.2
    Github ........ https://github.com/typeplate/starter-kit
    Authors ....... Dennis Gaebel (@gryghostvisuals) & Zachary Kain (@zakkain)
    License ....... Creative Commmons Attribution 3.0
    License URL ... https://github.com/typeplate/starter-kit/blob/master/license.txt
    */

      h1,
      h2,
      h3,
      h4,
      h5,
      h6 {
        text-rendering: optimizeLegibility;
        line-height: 1;
        margin-top: 0;
        color: #222;
      }

      blockquote + figcaption cite {
        display: block;
        font-size: inherit;
        text-align: right;
      }

      body {
        word-wrap: break-word;
      }

      pre code {
        word-wrap: normal;
      }

      body {
        -webkit-hyphens: auto;
        -ms-hyphens: auto;
        hyphens: auto;
        color: #444;
      }

      h1 {
        font-size: 2em;
        /* 2*16 = 32 */
      }

      h2 {
        font-size: 1.5em;
        /* 1.5*16 = 24 */
      }

      h3 {
        font-size: 1.17em;
        /* 1.17*16 = 18.72 */
      }

      h4 {
        font-size: 1em;
        /* 1*16 = 16 */
      }

      h5 {
        font-size: 0.83em;
        /* 0.83*16 = 13.28 */
      }

      h6 {
        font-size: 0.75em;
        /* 0.75*16 = 12 */
      }

      h1 {
        margin: 2.42424rem 0 1.454544rem;
      }

      h2 {
        margin: 2.0202rem 0 1.21212rem;
      }

      h3 {
        margin: 1.61616rem 0 1rem;
      }

      h4 {
        margin: 1.21212rem 0 1;
      }

      h5 {
        margin: 0.80808rem 0;
      }

      h6 {
        margin: 0.70707rem 0;
      }

      p {
        margin: auto auto 1.5rem;
      }

      small {
        font-size: 65%;
      }

      input,
      abbr,
      acronym,
      blockquote,
      code,
      kbd,
      q,
      samp,
      var {
        -webkit-hyphens: none;
        -ms-hyphens: none;
        hyphens: none;
      }

      pre {
        white-space: pre;
      }

      pre code {
        white-space: -moz-pre-wrap;
        white-space: pre-wrap;
      }

      code {
        white-space: pre;
        font-family: SF Mono, Consolas, Dejavu Sans Mono, Menlo, monospace;
      }

      abbr {
        -webkit-font-variant: small-caps;
        -moz-font-variant: small-caps;
        -ms-font-variant: small-caps;
        font-variant: small-caps;
        font-weight: 600;
        text-transform: lowercase;
        color: gray;
      }

      abbr[title]:hover {
        cursor: help;
      }

      /* FROM http://purecss.io/layouts/side-menu/  adapted to remove pure classes*/

      body {
        font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto,
          Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji",
          "Segoe UI Symbol";
        color: #444;
      }

      img {
        max-width: 100%;
        height: auto;
        display: block;
        margin: auto;
      }

      code,
      pre {
        background-color: #f5f5f5;
        color: #444;
        border-radius: 2px;
        text-shadow: 0px 1px 0px white;
        box-shadow: 0 1px 1px rgba(0, 0, 0, 0.15);
      }

      pre code {
        border: none;
        box-shadow: none;
      }

      pre {
        padding: 0.5em;
      }

      code {
        display: inline-block;
        padding: 0 0.5em;
        line-height: 1.4;
        font-size: 0.9em;
      }

      table {
        border-spacing: 0;
        margin-bottom: 1.5rem;
      }

      table th,
      table td {
        padding: 0.3em 0.7em;
      }

      table th {
        background-color: #f4f4f4;
        border-bottom: 2px solid #444;
      }

      table td {
        border: 1px solid #f5f5f5;
      }

      /* Add transition to containers so they can push in and out. */

      #layout,
      #menu,
      .menu-link {
        -webkit-transition: all 0.2s ease-out;
        -moz-transition: all 0.2s ease-out;
        -ms-transition: all 0.2s ease-out;
        -o-transition: all 0.2s ease-out;
        transition: all 0.2s ease-out;
      }

      /* This is the parent `<div>` that contains the menu and the content area. */

      #layout {
        position: relative;
        padding-left: 0;
      }

      #layout.active #menu {
        left: 250px;
        width: 250px;
      }

      #layout.active .menu-link {
        left: 250px;
      }

      /* The content `<div>` is where all your content goes. */

      .content {
        margin: 50px auto;
        padding: 0 2em;
        max-width: 80ex;
        line-height: 1.6em;
      }

      /*
      The `#menu` `<div>` is the parent `<div>` that contains the menu that
      appears on the left side of the page.
      */

      #menu {
        margin-left: -250px;
        /* "#menu" width */
        width: 250px;
        position: fixed;
        top: 0;
        left: 0;
        bottom: 0;
        z-index: 1000;
        /* so the menu or its navicon stays above all content */
        background: #f4f4f4;
        overflow-y: auto;
        -webkit-overflow-scrolling: touch;
        font-size: 0.9em;
      }

      @media print {
        #menu,
        .menu-link {
          display: none !important;
        }
      }

      a,
      a * {
        text-decoration: none;
        color: #2483cc;
      }

      a:visited {
        text-decoration: none;
        color: #2483cc;
      }

      /* All anchors inside the menu should be styled like this. */

      #menu a {
        display: block;
        padding: 0.5em 0.5em;
      }

      #menu a:first-letter {
        text-transform: capitalize;
      }

      #menu ul {
        list-style-type: none;
        padding: 0;
        margin: 1em 0.5em;
      }

      #menu ul ul {
        margin-top: 0.5em;
        margin-left: 0.5em;
        border-left: 4px solid rgba(255, 255, 255, 0.5);
      }

      /* Change color of the anchor links on hover/focus. */

      #menu li a:hover,
      #menu li a:focus {
        background: rgba(255, 255, 255, 0.4);
      }

      /* This styles the selected menu item `<li>`. */

      #menu li a.active {
        background: rgba(0, 0, 0, 0.05);
      }

      /* This styles a link within a selected menu item `<li>`. */

      #menu li a.active {
        color: #222;
      }

      /* This styles the menu heading. */

      #menu li.heading {
        font-size: 0.9em;
        text-transform: uppercase;
        color: #000;
      }

      #menu li.heading > * {
        padding: 0.5em;
        display: block;
      }

      #menu li.heading a {
        color: #0c68af;
      }

      /* -- Dynamic Button For Responsive Menu -------------------------------------*/

      /*
      `.menu-link` represents the responsive menu toggle that shows/hides on
      small screens.
      */

      .menu-link {
        position: fixed;
        display: block;
        /* show this only on small screens */
        top: 0;
        left: 0;
        /* "#menu width" */
        font-size: 10px;
        /* change this value to increase/decrease button size */
        z-index: 10;
        width: 2em;
        height: auto;
        padding: 1.6em 1.2em;
        border-radius: 0 2px 2px 0;
      }

      .menu-link:hover {
        background: #f4f4f4;
      }

      .menu-link span {
        position: relative;
        display: block;
      }

      .menu-link span,
      .menu-link span:before,
      .menu-link span:after {
        background-color: #555;
        width: 100%;
        height: 0.2em;
        border-radius: 1em;
      }

      .menu-link span:before,
      .menu-link span:after {
        position: absolute;
        margin-top: -0.6em;
        content: " ";
      }

      .menu-link span:after {
        margin-top: 0.6em;
      }

      /* Hides the menu at `48em`, but modify this based on your app's needs. */

      @media (min-width: 48em) {
        .header,
        .content {
          padding-left: 2em;
          padding-right: 2em;
        }

        #layout {
          padding-left: 250px;
          /* left col width "#menu" */
          left: 0;
        }
        #menu {
          left: 250px;
        }

        .menu-link {
          position: fixed;
          left: 250px;
          display: none;
        }

        #layout.active .menu-link {
          left: 250px;
        }
      }

      @media (max-width: 48em) {
        /* Only apply this when the window is small. Otherwise, the following case results in extra padding on the left:
         * Make the window small.
         * Tap the menu to trigger the active state.
         * Make the window large again.
         */
        #layout.active {
          position: relative;
          left: 250px;
        }
      }

      /* Heading anchors and permalinks */
      h1[id],
      h2[id],
      h3[id],
      h4[id],
      h5[id],
      h6[id] {
        position: relative;
      }
      .heading-anchor-permalink {
        /* Position the permalink to the left of the title */
        position: absolute;
        right: 100%;
        /* Add some spacing as padding to not lose the hover */
        padding-right: 0.6rem;
        /* Make it only visible on heading hover, see below */
        opacity: 0;
      }
      h1[id]:hover .heading-anchor-permalink,
      h2[id]:hover .heading-anchor-permalink,
      h3[id]:hover .heading-anchor-permalink,
      h4[id]:hover .heading-anchor-permalink,
      h5[id]:hover .heading-anchor-permalink,
      h6[id]:hover .heading-anchor-permalink {
        opacity: 0.5;
      }
    </style>
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta charset="utf-8" />
  </head>

  <body>
    <div id="layout">
      <!-- Menu toggle -->
      <a href="#menu" id="menuLink" class="menu-link">
        <!-- Hamburger icon -->
        <span></span>
      </a>
      <nav id="menu">
        <ul>
<li class="heading"><a class="" href="..\..\index.html">notes</a></li>
<ul>
<li class="heading"><span>Approaches</span></li>
<ul>
<li><a class="" href="..\..\Approaches\Approach to Pedal Edema.html">Approach to Pedal Edema</a></li>
<li><a class="" href="..\..\Approaches\Approach to QTc prolongation.html">Approach to QTc prolongation</a></li>
<li><a class="" href="..\..\Approaches\Bradycardia.html">Bradycardia</a></li>
<li><a class="" href="..\..\Approaches\Tachycardia.html">Tachycardia</a></li>
<li><a class="" href="..\..\Approaches\Workup of First episode psychosis.html">Workup of First episode psychosis</a></li>
</ul>
<li class="heading"><span>Casc</span></li>
<ul>
<li><a class="" href="..\..\Casc\Alcohol history.html">Alcohol history</a></li>
<li><a class="" href="..\..\Casc\Grief reaction.html">Grief reaction</a></li>
<li><a class="" href="..\..\Casc\approach to psychooncology.html">approach to psychooncology</a></li>
</ul>
<li class="heading"><span>Psychiatry</span></li>
<ul>
<li class="heading"><span>Core psychiatry</span></li>
<ul>
<li><a class="" href="..\Core psychiatry\Antipsychotic monitoring.html">Antipsychotic monitoring</a></li>
<li><a class="" href="..\Core psychiatry\Antipsychotic prophylaxis.html">Antipsychotic prophylaxis</a></li>
<li><a class="" href="..\Core psychiatry\Dosage of antipsychotics.html">Dosage of antipsychotics</a></li>
<li><a class="" href="..\Core psychiatry\High dose Antipsychotics.html">High dose Antipsychotics</a></li>
<li><a class="" href="..\Core psychiatry\How Exercise changes the Brain_.html">How Exercise changes the Brain </a></li>
<li><a class="" href="..\Core psychiatry\How I handled an EMR prescription error today.html">How I handled an EMR prescription error today</a></li>
<li><a class="" href="..\Core psychiatry\How to choose an antipsychotic_.html">How to choose an antipsychotic </a></li>
<li><a class="" href="..\Core psychiatry\Importance of Mental Health in Human Life.html">Importance of Mental Health in Human Life</a></li>
<li><a class="" href="..\Core psychiatry\Negative Symptoms Schizophrenia.html">Negative Symptoms Schizophrenia</a></li>
<li><a class="" href="..\Core psychiatry\PreschoolADHDDrugDrugChoice.html">PreschoolADHDDrugDrugChoice</a></li>
<li><a class="" href="..\Core psychiatry\Should we combing antipsychotics_.html">Should we combing antipsychotics </a></li>
<li><a class="" href="..\Core psychiatry\Treating a Friend.html">Treating a Friend</a></li>
<li><a class="" href="..\Core psychiatry\What predicts outcome in Schizophreniaʔ.html">What predicts outcome in Schizophreniaʔ</a></li>
<li><a class="" href="..\Core psychiatry\bipolar in child bearing age group.html">bipolar in child bearing age group</a></li>
</ul>
<li class="heading"><span>bookreading</span></li>
<ul>
<li><a class="" href="..\bookreading\bookreading17062021.html">bookreading17062021</a></li>
</ul>
<li class="heading"><span>community psych</span></li>
<ul>
<li><a class="" href="..\community psych\Challenges faced by community-level workers in del.html">Challenges faced by community level workers in del</a></li>
</ul>
<li class="heading"><span>consultation liaison</span></li>
<ul>
<li><a class="" href="..\consultation-liaison\renal_case_psychiatry.html">renal case psychiatry</a></li>
</ul>
<li class="heading"><span>covid</span></li>
<ul>
<li><a class="" href="COVID platelets and serotonin.html">COVID platelets and serotonin</a></li>
<li><a class="" href="COVID update number 9.html">COVID update number 9</a></li>
<li><a class="" href="Drbasucomments.html">Drbasucomments</a></li>
<li><a class="" href="Psychosocial impact of COVID-19.html">Psychosocial impact of COVID 19</a></li>
<li><a class="active" href="SSRI IN COVID-19.html">SSRI IN COVID 19</a></li>
<li><a class="" href="nationalWebinarStressHCW.html">nationalWebinarStressHCW</a></li>
</ul>
<li class="heading"><span>neuropsychiatry</span></li>
<ul>
<li><a class="" href="..\neuropsychiatry\DD of psychosis detailed.html">DD of psychosis detailed</a></li>
<li><a class="" href="..\neuropsychiatry\DD of psychosis simple.html">DD of psychosis simple</a></li>
<li><a class="" href="..\neuropsychiatry\Differentiating Encephalopathy from psychosis.html">Differentiating Encephalopathy from psychosis</a></li>
<li><a class="" href="..\neuropsychiatry\Fahr Syndrome.html">Fahr Syndrome</a></li>
<li><a class="" href="..\neuropsychiatry\Gut Microbiome in Depression.html">Gut Microbiome in Depression</a></li>
<li><a class="" href="..\neuropsychiatry\Manganism.html">Manganism</a></li>
<li><a class="" href="..\neuropsychiatry\NBIA.html">NBIA</a></li>
<li><a class="" href="..\neuropsychiatry\Neurocircuit taxonomy.html">Neurocircuit taxonomy</a></li>
<li><a class="" href="..\neuropsychiatry\Parkinsonism.html">Parkinsonism</a></li>
<li><a class="" href="..\neuropsychiatry\catatonia.html">catatonia</a></li>
</ul>
</ul>
<li class="heading"><span>Research</span></li>
<ul>
<li class="heading"><span>Abhishek</span></li>
<ul>
<li><a class="" href="..\..\Research\Abhishek\Suffering_interview.html">Suffering interview</a></li>
</ul>
<li class="heading"><span>PostCOVID</span></li>
<ul>
<li><a class="" href="..\..\Research\PostCOVID\PostCOVID_screening.html">PostCOVID screening</a></li>
</ul>
</ul>
<li class="heading"><span>UG</span></li>
<ul>
<li><a class="" href="..\..\UG\PG education subcommittee discussion forum.html">PG education subcommittee discussion forum</a></li>
<li><a class="" href="..\..\UG\Psychiatry_as_major_subject_UG.html">Psychiatry as major subject UG</a></li>
<li><a class="" href="..\..\UG\Viva- Chapter History and MSE.html">Viva  Chapter History and MSE</a></li>
<li><a class="" href="..\..\UG\viva mood disorders.html">viva mood disorders</a></li>
<li><a class="" href="..\..\UG\viva psychosis.html">viva psychosis</a></li>
</ul>

</ul>
</ul>
      </nav>
      <article id="main" class="content">
        <p>SSRI IN COVID-19</p>
<h1 id="ssri-in-covid-19">SSRI IN COVID 19 <a class="heading-anchor-permalink" href="#ssri-in-covid-19">#</a></h1>
<p>Edit date: 26/06/2021 11:09</p>
<p><strong>CONTENTS</strong></p>
<hr>
<ul>
<li><a href="#ssri-in-covid-19">SSRI IN COVID 19</a></li>
<li><a href="#the-possible-immunoregulatory-and-anti-inflammatory-effects-of-selective-serotonin-reuptake-inhibitors-in-coronavirus-disease-patients">The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients</a>
<ul>
<li><a href="#hamed-et-al-medical-hypothesis-2020">Hamed et al Medical Hypothesis 2020</a>
<ul>
<li><a href="#immune-dysregulation-in-covid-19">Immune dysregulation in COVID-19</a></li>
<li><a href="#5-ht-and-immnunity">5-HT and immnunity</a></li>
<li><a href="#hypothesis">Hypothesis</a></li>
<li><a href="#which-ssri-is-suited">Which SSRI is suited?</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19---a-randomized-clinical-trial">Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 - A Randomized Clinical Trial</a>
<ul>
<li><a href="#lenze-et-al-jama-2020">Lenze et al JAMA 2020</a></li>
</ul>
</li>
<li><a href="#association-between-antidepressant-use-and-reduced-risk-of-intubation-or-death-in-hospitalized-patients-with-covid-19-results-from-an-observational-study">Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study</a>
<ul>
<li><a href="#hortel-el-al-molecular-psychiatry-2021">Hortel el al Molecular Psychiatry 2021</a></li>
</ul>
</li>
<li><a href="#bottom-line">Bottom line</a></li>
</ul>
<hr>
<h1 id="the-possible-immunoregulatory-and-anti-inflammatory-effects-of-selective-serotonin-reuptake-inhibitors-in-coronavirus-disease-patients">The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients <a class="heading-anchor-permalink" href="#the-possible-immunoregulatory-and-anti-inflammatory-effects-of-selective-serotonin-reuptake-inhibitors-in-coronavirus-disease-patients">#</a></h1>
<h2 id="hamed-et-al-medical-hypothesis-2020">Hamed et al Medical Hypothesis 2020 <a class="heading-anchor-permalink" href="#hamed-et-al-medical-hypothesis-2020">#</a></h2>
<h3 id="immune-dysregulation-in-covid-19">Immune dysregulation in COVID-19 <a class="heading-anchor-permalink" href="#immune-dysregulation-in-covid-19">#</a></h3>
<ul>
<li>is a consequence of elevation of cortisol, the stress hormone, and reduction of serotonin</li>
<li>Stressful conditions associated with infection had shown to cause an elevation in the levels of the inflammatory mediator IL-6 that causes a decrease in the number and activity of cytotoxic T-cells and natural killer (NK) cells</li>
<li>Elevated inflammatory cytokines have been shown to precipitate inflammations in many organs especially lung which is a serious condition and a main cause of mortality in COVID-19</li>
</ul>
<h3 id="5-ht-and-immnunity">5-HT and immnunity <a class="heading-anchor-permalink" href="#5-ht-and-immnunity">#</a></h3>
<ul>
<li>5-HT has been found to regulate innate and adaptive immune responses</li>
<li>Elevated cytokine levels have been shown to increase the rate of metabolism of serotonin due to activation of indoleamine-2,3-dioxygenase (IDO) enzyme that metabolizes tryptophan which is the precursor of serotonin</li>
</ul>
<h3 id="hypothesis">Hypothesis <a class="heading-anchor-permalink" href="#hypothesis">#</a></h3>
<ul>
<li>Antidepressants are found to augment the immune system response through inhibiting pro-inflammatory factors, in particular CRP, TNF-α, IL-1β and IL-6</li>
<li>SSRIs increase serotonin via proscribing its reuptake into the presynaptic cell then increasing the level of serotonin inside the synaptic cleft to bind the postsynaptic receptor</li>
<li>This class had been proved to prevent the elevation of cytokine levels which causes depression</li>
<li>In vitro antibacterial effect and modulation of antibiotic activity were also associated with using SSRIs</li>
</ul>
<p align="center">
  <img width="460" height="300" style="padding:1px;border:thin solid black;" src="https://ars.els-cdn.com/content/image/1-s2.0-S096758682100120X-ga1_lrg.jpg"></br>
  Figure: Drug repurposing of SSRIs
</p>
<ul>
<li><strong>In COVID-19 patients, SSRIs may help in hindering cytokine release syndrome that is responsible for aggravating sickness progression and the subsequent increase in TNFα</strong></li>
<li>SSRIs also have anti-coagulant properties</li>
</ul>
<h3 id="which-ssri-is-suited%3F">Which SSRI is suited? <a class="heading-anchor-permalink" href="#which-ssri-is-suited%3F">#</a></h3>
<ul>
<li><strong>Sertraline</strong> wide therapeutic index</li>
<li>low anticholinergic t/f good for elderly and cardiac</li>
<li>shown to regulate pro-inflammatory cytokines
augment action of antibiotics against S. Aureus, E. Coli and P. Aeruginosa</li>
<li>reduced influenza-induced lung inflammation when combined with oseltamivir in mouse model</li>
</ul>
<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382922/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382922/</a></p>
<p>Additional reference</p>
<ol>
<li>
<p>Pashaei <a href="https://www.sciencedirect.com/science/article/pii/S096758682100120X">J Clin Neuroscience 2021</a></p>
</li>
<li>
<p>Navin <a href="https://journals.sagepub.com/doi/full/10.1177/0253717620963338">Indian J Psychol Med</a></p>
</li>
</ol>
<h1 id="fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19---a-randomized-clinical-trial">Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 - A Randomized Clinical Trial <a class="heading-anchor-permalink" href="#fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19---a-randomized-clinical-trial">#</a></h1>
<h2 id="lenze-et-al-jama-2020">Lenze et al JAMA 2020 <a class="heading-anchor-permalink" href="#lenze-et-al-jama-2020">#</a></h2>
<ul>
<li>
<p>Question: Does fluvoxamine, a selective serotonin reuptake inhibitor and σ-1 receptor agonist, prevent clinical deterioration in outpatients with acute coronavirus disease 2019 (COVID-19)?</p>
</li>
<li>
<p>Findings: In this randomized trial that included 152 adult outpatients with confirmed COVID-19 and symptom onset within 7 days, clinical deterioration occurred in 0 patients treated with fluvoxamine vs 6 (8.3%) patients treated with placebo over 15 days, a difference that was statistically significant.</p>
</li>
<li>
<p>Meaning: In this preliminary study, adult outpatients with symptomatic COVID-19 treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration over 15 days; however, determination of clinical efficacy would require larger randomized trials with more definitive outcome measures.</p>
<p><a href="https://jamanetwork.com/journals/jama/fullarticle/2773108">https://jamanetwork.com/journals/jama/fullarticle/2773108</a></p>
</li>
</ul>
<h1 id="association-between-antidepressant-use-and-reduced-risk-of-intubation-or-death-in-hospitalized-patients-with-covid-19%3A-results-from-an-observational-study">Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study <a class="heading-anchor-permalink" href="#association-between-antidepressant-use-and-reduced-risk-of-intubation-or-death-in-hospitalized-patients-with-covid-19%3A-results-from-an-observational-study">#</a></h1>
<h2 id="hortel-el-al-molecular-psychiatry-2021">Hortel el al Molecular Psychiatry 2021 <a class="heading-anchor-permalink" href="#hortel-el-al-molecular-psychiatry-2021">#</a></h2>
<ul>
<li>prior meta-analysis showed that antidepressant use in major depressive disorder was associated with reduced plasma levels of several pro-inflammatory mediators</li>
<li>antidepressants may inhibit acid sphingomyelinase activity, which may prevent the infection of epithelial cells with SARS-CoV-2</li>
<li>Observational multicenter retrospective cohort study [PARIS]</li>
<li>Primary endpoint was a composite of intubation or death</li>
<li>Of 7230 adults hospitalized for COVID-19, 345 patients (4.8%) received an antidepressant within 48 h of hospital admission.</li>
<li>Compared endpoint between patients who received antidepressants and those who did not in time-to-event analyses adjusted for patient characteristics, clinical and biological markers of disease severity, and other psychotropic medications</li>
<li>Significant association between antidepressant use and reduced risk of intubation or death (HR, 0.56; 95% CI, 0.43–0.73, p &lt; 0.001).</li>
<li>Association was also significant for SSRI and non-SSRI antidepressants, and for fluoxetine, paroxetine, escitalopram, venlafaxine, and mirtazapine (all p &lt; 0.05).</li>
</ul>
<p><a href="https://www.nature.com/articles/s41380-021-01021-4">https://www.nature.com/articles/s41380-021-01021-4</a></p>
<h1 id="bottom-line">Bottom line <a class="heading-anchor-permalink" href="#bottom-line">#</a></h1>
<ul>
<li>Cytokines increase tryptophan metabolism (serotonin precursor) by increasing IDO enzyme activity</li>
<li>Single RCT of Fluvoxamine an SSRI and σ-1 receptor agonist shown promise</li>
<li>Observational study of those already on antidepressants, association with reduced intubation or death</li>
<li>Possible MOA
<ul>
<li>Inhibition of acid sphingomyelinase activity -&gt; prevent further infection</li>
<li>Reduced plasma proinflammatory cytokines</li>
</ul>
</li>
<li>Sertraline has both σ-1 agonism and an SSRI, also cardiac safe and low risk of drug-srug ineractions [OFF-LABEL USE??? ON CASE TO CASE BASIS; USE FOR RX OF COMORBID ANXIETY AND DEPRESSION WHRERE CLINCALLY INDICATED]</li>
<li>speculated ideal time to start once respiratory symptom begin to be worse (i.e. before the onset of acute lung injury)</li>
<li>Navin et al have raised concerns about potential risks with SSRI in SARS-COV2, such as impaired coagulation, risk of arrhythmias, liver injury, and cytochrome-mediated drug interactions, which can potentially limit the use of SSRI in such patients</li>
<li>Further double blind RCTs are required</li>
</ul>

      </article>
    </div>
    <script>
      // Load contents.json if you need it
    </script>
    <script>
      // FROM http://purecss.io/js/ui.js
      (function(window, document) {
        var layout = document.getElementById("layout"),
          menu = document.getElementById("menu"),
          menuLink = document.getElementById("menuLink");

        function toggleClass(element, className) {
          var classes = element.className.split(/\s+/),
            length = classes.length,
            i = 0;

          for (; i < length; i++) {
            if (classes[i] === className) {
              classes.splice(i, 1);
              break;
            }
          }
          // The className is not found
          if (length === classes.length) {
            classes.push(className);
          }

          element.className = classes.join(" ");
        }

        menuLink.onclick = function(e) {
          var active = "active";

          e.preventDefault();
          toggleClass(layout, active);
          toggleClass(menu, active);
          toggleClass(menuLink, active);
        };
      })(this, this.document);
    </script>
  </body>
</html>
